Publication: GX-G3, a Long-Acting G-CSF, Compared with Pegfilgrastim in Reducing Duration of Severe Neutropenia After Chemotherapy for Non-Hodgkin's Lymphoma
| dc.contributor.author | Ertan-Ahmed, Senem | |
| dc.contributor.author | Kiehl, Michael G. | |
| dc.contributor.author | Radinoff, Atanas | |
| dc.contributor.author | Graklanov, Vasko | |
| dc.contributor.author | Tzvetkov, Nikolay | |
| dc.contributor.author | Mihaescu, Rodica | |
| dc.contributor.author | Sung, Young Chul | |
| dc.contributor.authorID | Graklanov, Vasko/0000-0002-7059-1411 | |
| dc.date.accessioned | 2020-06-21T12:26:54Z | |
| dc.date.available | 2020-06-21T12:26:54Z | |
| dc.date.issued | 2019 | |
| dc.department | OMÜ | en_US |
| dc.department-temp | ILKOGEN, Dept Clin Res, Istanbul, Turkey -- Clin Frankfurt Oder GmbH, Frankfurt, Germany -- UMHAT Sveti Ivan Rilski EOOD, Dept Clin Clin Hematol, Sofia, Bulgaria -- UMHAT Sveti Georgi EAD, Dept Clin Hematol, Sofia, Bulgaria -- UMHAT Georgi Stranski EAD, Dept Clin Hematol, Sofia, Bulgaria -- Univ Med & Farm Timisoara, Dept Internal Med, Timisoara, Romania -- Ondokuz Mayis Univ, Fac Med, Dept Hematol, Samsun, Turkey | en_US |
| dc.description | Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) -- MAY 31-JUN 04, 2019 -- Chicago, IL | en_US |
| dc.description.abstract | … | en_US |
| dc.description.sponsorship | Amer Soc Clin Oncol | en_US |
| dc.identifier.issn | 0732-183X | |
| dc.identifier.issn | 1527-7755 | |
| dc.identifier.issue | 15 | en_US |
| dc.identifier.uri | https://hdl.handle.net/20.500.12712/10834 | |
| dc.identifier.volume | 37 | en_US |
| dc.identifier.wos | WOS:000487345802410 | |
| dc.language.iso | en | en_US |
| dc.publisher | Amer Soc Clinical Oncology | en_US |
| dc.relation.journal | Journal of Clinical Oncology | en_US |
| dc.relation.publicationcategory | Konferans Öğesi - Uluslararası - Kurum Öğretim Elemanı | en_US |
| dc.rights | info:eu-repo/semantics/closedAccess | en_US |
| dc.title | GX-G3, a Long-Acting G-CSF, Compared with Pegfilgrastim in Reducing Duration of Severe Neutropenia After Chemotherapy for Non-Hodgkin's Lymphoma | en_US |
| dc.type | Conference Object | en_US |
| dspace.entity.type | Publication |
